Three quick details:
1. The board approved a quarterly cash dividend of $0.24 per share for the second quarter of 2020.
2. The dividend is payable July 31 to stockholders of record as of the close of business June 29.
3. Zimmer Biomet’s first-quarter report showed a 9.7 percent decline in net sales to $1.78 billion, as well as a net loss of $509 million.
More articles on devices:
Medtronic’s pipeline includes spine, robotics innovations despite pandemic setbacks
3 spine, neurosurgery device recalls in the past year
Aetna to cover sacroiliac joint fusion under new policy
